Suppressive effect of herbal compound 861 on chemical hepatocarcinogenesis in rats.
- Author:
Rutao CUI
1
;
Baoen WANG
;
Fukui ZHANG
;
Guangyong CHEN
;
Shanshan YIN
Author Information
- Publication Type:Journal Article
- MeSH: 2-Acetylaminofluorene; Animals; Blotting, Northern; Blotting, Western; Body Weight; Diethylnitrosamine; Drugs, Chinese Herbal; therapeutic use; Female; Glutathione Transferase; genetics; Liver; pathology; Liver Neoplasms, Experimental; chemically induced; drug therapy; pathology; Organ Size; Rats; Rats, Sprague-Dawley
- From: Chinese Medical Journal 2003;116(3):378-382
- CountryChina
- Language:English
-
Abstract:
OBJECTIVETo investigate the effects of herbal compound 861 (Cpd861) on hepatocarcinogenesis induced by diethylntrosamine and 2-acetylaminofluorene (DEN-AAF) in female Sprague Dawley rats.
METHODSLiver preneoplastic foci were induced using the DEN-AAF method in female Sprague Dawley rats, which were then treated with Cpd861. For quantitative assessment of liver preneoplastic foci, the placental form of glutathione-S-transferase (GST-P) positive foci were measured using immunohistochemical staining and image analysis. GST-P protein expression was measured by Western blotting, mRNA expression was assessed by Northern blotting.
RESULTSTreatment using DEN-AAF caused a significant decrease in body weight and increase in liver weight compared to the control group. Oral Cpd861 administration essentially prevented DEN-AAF-induced body weight loss and liver weight increase. When 2-AAF was followed by treatment with Cpd861, there was a decrease in the number of large foci as compared to 2-AAF alone. However, there were still considerable numbers of small mixed clear/vacuolated cell foci, some of which were positive for GST-P. Significant increase in GST-P protein and mRNA expression were observed in the DEN-AAF group, while treatment with Cpd861 inhibited the increase. The effect of Cpd861 on hepatocarcinogenesis occurred in a concentration-dependent manner.
CONCLUSIONChinese herbal compound Cpd861 prevents hepatocarcinogenesis in DEN-AAF-induced liver preneoplastic lesions in rats.